NovoCure Ltd logo

NovoCure Ltd

STU:038 (Jersey)  
€ 11.41 (-3.84%) Dec 8
At Loss
P/B:
3.39
Market Cap:
€ 1.24B ($ 1.33B)
Enterprise V:
€ 931.00M ($ 1.00B)
Volume:
1.00
Avg Vol (2M):
74.00
Also Trade In:
Volume:
1.00
At Loss
Avg Vol (2M):
74.00

Business Description

Description
NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Ovarian Cancer, Pancreatic Cancer, Non-Small Cell Lung Cancer, and Brain Metastasis. Products are comprised of two main components: electric field generator and arrays and related accessories. NovoCure derives its major revenues in the United States.
Name Current Vs Industry Vs History
Cash-To-Debt 1.56
Equity-to-Asset 0.34
Debt-to-Equity 1.5
Debt-to-EBITDA -2.92
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0.76
Distress
Grey
Safe
Beneish M-Score -3.14
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 45.35
9-Day RSI 47.8
14-Day RSI 44.84
6-1 Month Momentum % -72.77
12-1 Month Momentum % -83.44

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 6.67
Quick Ratio 6.43
Cash Ratio 5.86
Days Inventory 92.4
Days Sales Outstanding 55.73
Days Payable 237.78

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -1.8
Shareholder Yield % -0.56

Financials (Next Earnings Date:2024-02-23 Est.)

STU:038's 30-Y Financials
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

NovoCure Ltd Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 471
EPS (TTM) (€) -1.736
Beta 0.22
Volatility % 71.22
14-Day RSI 44.84
14-Day ATR (€) 0.398236
20-Day SMA (€) 11.20475
12-1 Month Momentum % -83.44
52-Week Range (€) 10.425 - 117
Shares Outstanding (Mil) 106.86

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

NovoCure Ltd Filings

Filing Date Document Date Form
No Filing Data

NovoCure Ltd Stock Events

Event Date Price(€)
No Event Data

NovoCure Ltd Frequently Asked Questions

What is NovoCure Ltd(STU:038)'s stock price today?
The current price of STU:038 is €11.41. The 52 week high of STU:038 is €117.00 and 52 week low is €10.43.
When is next earnings date of NovoCure Ltd(STU:038)?
The next earnings date of NovoCure Ltd(STU:038) is 2024-02-23 Est..
Does NovoCure Ltd(STU:038) pay dividends? If so, how much?
NovoCure Ltd(STU:038) does not pay dividend.

Press Release

Subject Date
No Press Release